Skip to main content

Gotcha!: Jul 6, 2012


Cornell University's Brian Kirby and his colleagues reported on their development of a 'sticky' silicon chip known as geometrically enhanced differential immunocapture, or GEDI, in PLoS One in April. Now, Kirby tells the Cornell Chronicle, the researchers are applying this new cell-capture device to trap circulating tumor cells in blood samples from patients with metastatic cancers.

"Most cancer cells are bigger and more rigid than normal cells, so it's about tricking these cancer cells into colliding with the sticky walls," Kirby tells the Cornell Chronicle. The paper adds that the GEDI device is slated to go to clinical trial this year, and the Kirby and his colleagues "are actively working on detectors for breast, ovarian and pancreatic cancers."

HT: Fierce Health IT

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.